Vilin Bio Med Limited
IPO Details
Subscription
Lot Distribution
Reservation
Company Fin.
₹0(0.00%)
Premium (ELP)
The public market debut of Vilin Bio Med Limited's was completed on Jun 30, 2023 with its listing on the NSE exchange. The IPO process raised 40,00,000 Shares in total capital, consisting of 40,00,000 Shares in new equity.
The offering featured a price range of ₹30 to ₹30 and minimum application size of 4000 shares. Investor response during the subscription period from Jun 16, 2023 to Jun 21, 2023 influenced the final allotment ratios across investor categories.
Final allotment was announced on Jun 26, 2023, distributing shares to successful subscribers. The listing established a continuous market for the company's shares, enabling liquidity, valuation transparency, and broader investor participation.
Investors can bid starting from the minimum lot size specified for this IPO, and only in multiples of that lot size. The table below shows the minimum and maximum investment for retail investors and HNIs in terms of lots, quantity, and amount.
Incorporated in 2005, Vilin Bio Med Limited is engaged in the domestic manufacturing of pharmaceutical products, supplying in bulk to pharmaceutical manufacturers, marketers, and traders who distribute them to end customers. The company’s product range includes Oral Liquids (Syrups, Suspensions, Dry Powders – both βeta and Non-βeta-Lactam), Tablets and Capsules (βeta and Non-βeta-Lactam), External Preparations, and Dry Powders. Vilin Bio Med operates its R&D center and manufacturing facility in Roorkee, Uttarakhand, ensuring quality and innovation in production. The company reported revenue of ₹1,121.91 lakhs in FY2022 and ₹1,171.88 lakhs in FY2021.
Note : "Calculations for ‘Shares Offered’ and ‘Total Amount’ are based on the highest price in the issue price band."
NA
NA
- Viswa Prasad Sadhanala
- Sadhanala Venkata Rao
- D. Srinivasa Reddy
- Ramesh Reddy Sama
Vilin Bio Med Limited
Bigshare Services Private Limited